Mutations in TP53 and DNA damage repair genes have a negative impact on the response to first-line systemic therapy in men with prostate cancer

被引：0
|
作者：
Nientiedt, C. [1 ,2 ]
Wuenschel, A. -K [3 ]
Kaczorowski, A. [3 ]
Endris, V [4 ]
Zschaebitz, S. [1 ]
Jaeger, D. [1 ]
Hohenfellner, M. [5 ]
Stenzinger, A.
Duensing, S. [3 ]
机构：
[1] NCT Natl Ctr Tumorerkrankungen Heidelberg, Med Onkol, Heidelberg, Germany
[2] Klin Innere Med Hamatol Onkol & Stammzelltranspla, Freiburg, Germany
[3] Urol Clin, Mol Uroonkol, Heidelberg, Germany
[4] Pathol Inst, Allgemeine Pathol, Heidelberg, Germany
[5] Urol Clin, Heidelberg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2023年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V836
引用
收藏
页码：112 / 112
页数：1
相关论文
共 50 条
  • [1] Mutations in TP53 or DNA damage repair genes define poor prognostic subgroups in primary prostate cancer
    Nientiedt, Cathleen
    Budczies, Jan
    Endris, Volker
    Kirchner, Martina
    Schwab, Constantin
    Jurcic, Christina
    Behnisch, Rouven
    Hoveida, Shirin
    Lantwin, Philippa
    Kaczorowski, Adam
    Geisler, Christine
    Dieffenbacher, Svenja
    Falkenbach, Fabian
    Franke, Desiree
    Goertz, Magdalena
    Heller, Martina
    Himmelsbach, Ruth
    Pecqueux, Carine
    Rath, Mathias
    Reimold, Philipp
    Schuetz, Viktoria
    Simunovic, Iva
    Walter, Elena
    Hofer, Luisa
    Gasch, Claudia
    Schoenberg, Gita
    Pursche, Lars
    Hatiboglu, Gencay
    Nyarangi-Dix, Joanne
    Sueltmann, Holger
    Zschaebitz, Stefanie
    Koerber, Stefan A.
    Jaeger, Dirk
    Debus, Jurgen
    Duensing, Anette
    Schirmacher, Peter
    Hohenfellner, Markus
    Stenzinger, Albrecht
    Duensing, Stefan
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (01) : 8.e11 - 8.e18
  • [2] Genomic landscape of liquid biopsy mutations in TP53 and DNA damage genes in cancer patients
    Damien Vasseur
    Ahmadreza Arbab
    Fabiola Giudici
    Christophe Marzac
    Stefan Michiels
    Marco Tagliamento
    Arnaud Bayle
    Cristina Smolenschi
    Madona Sakkal
    Mihaela Aldea
    Hela Sassi
    Filippo Gustavo Dall’Olio
    Noémie Pata-Merci
    Sophie Cotteret
    Alice Fiévet
    Nathalie Auger
    Luc Friboulet
    Francesco Facchinetti
    Arthur Géraud
    Santiago Ponce
    Antoine Hollebecque
    Benjamin Besse
    Jean Baptiste Micol
    Antoine Italiano
    Ludovic Lacroix
    Etienne Rouleau
    npj Precision Oncology, 8
  • [3] Genomic landscape of liquid biopsy mutations in TP53 and DNA damage genes in cancer patients
    Vasseur, Damien
    Arbab, Ahmadreza
    Giudici, Fabiola
    Marzac, Christophe
    Michiels, Stefan
    Tagliamento, Marco
    Bayle, Arnaud
    Smolenschi, Cristina
    Sakkal, Madona
    Aldea, Mihaela
    Sassi, Hela
    Dall'Olio, Filippo Gustavo
    Pata-Merci, Noemie
    Cotteret, Sophie
    Fievet, Alice
    Auger, Nathalie
    Friboulet, Luc
    Facchinetti, Francesco
    Geraud, Arthur
    Ponce, Santiago
    Hollebecque, Antoine
    Besse, Benjamin
    Micol, Jean Baptiste
    Italiano, Antoine
    Lacroix, Ludovic
    Rouleau, Etienne
    NPJ PRECISION ONCOLOGY, 2024, 8 (01)
  • [4] Impact of TP53/KRAS mutations on overall survival of metastatic non-small cell lung cancer patients (pts) treated with systemic first-line therapy
    Novella, S. Rubio
    Cobo, A.
    Montes, A.
    Lopez, J. Soler
    Rondan, M. Arnal
    Palanca, S. Noguera
    Tena, I.
    Miguel, J.
    Navarro, B.
    Domingo, I.
    Esteban, S. Cases
    Diaz, M.
    Andrade, P.
    Rosello, E.
    Santander, J. R. Lazaro
    Estelles, D. Lorente
    Hernandez, A. Sanchez
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S80 - S81
  • [5] Functional TP53 mutations have no impact on response to cytotoxic agents in metastatic colon cancer
    Netter, Jeanne
    Lehmann-Che, Jacqueline
    Lambert, Jerome
    Tallet, Anne
    Lourenco, Nelson
    Soliman, Hany
    Bertheau, Philippe
    Pariente, Benjamin
    Chirica, Mircea
    Pocard, Marc
    Allez, Matthieu
    De The, Hugues
    Gornet, Jean-Marc
    BULLETIN DU CANCER, 2015, 102 (02) : 117 - 125
  • [6] Epigenetic regulation of TP53 is involved in prostate cancer radioresistance and DNA damage response signaling
    Macedo-Silva, Catarina
    Miranda-Goncalves, Vera
    Tavares, Nuno Tiago
    Barros-Silva, Daniela
    Lencart, Joana
    Lobo, Joao
    Oliveira, Angelo
    Correia, Margareta P.
    Altucci, Lucia
    Jeronimo, Carmen
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
  • [7] Epigenetic regulation of TP53 is involved in prostate cancer radioresistance and DNA damage response signaling
    Catarina Macedo-Silva
    Vera Miranda-Gonçalves
    Nuno Tiago Tavares
    Daniela Barros-Silva
    Joana Lencart
    João Lobo
    Ângelo Oliveira
    Margareta P. Correia
    Lucia Altucci
    Carmen Jerónimo
    Signal Transduction and Targeted Therapy, 8
  • [8] First-line immunotherapy for lung cancer with MET exon 14 skipping and the relevance of TP53 mutations
    Blasi, Miriam
    Kuon, Jonas
    Lueders, Heike
    Misch, Daniel
    Kauffmann-Guerrero, Diego
    Hilbrandt, Moritz
    Kazdal, Daniel
    Falkenstern-Ge, Roger-Fei
    Hackanson, Bjoern
    Dintner, Sebastian
    Faehling, Martin
    Kirchner, Martina
    Volckmar, Anna -Lena
    Kopp, Hans -Georg
    Allgaeuer, Michael
    Grohe, Christian
    Tufman, Amanda
    Reck, Martin
    Frost, Nikolaj
    Stenzinger, Albrecht
    Thomas, Michael
    Christopoulos, Petros
    EUROPEAN JOURNAL OF CANCER, 2024, 199
  • [9] Impact of TP53 Mutations on Outcome in EGFR-Mutated Patients Treated with First-Line Tyrosine Kinase Inhibitors
    Canale, Matteo
    Petracci, Elisabetta
    Delmonte, Angelo
    Chiadini, Elisa
    Dazzi, Claudio
    Papi, Maximilian
    Capelli, Laura
    Casanova, Claudia
    De Luigi, Nicoletta
    Mariotti, Marita
    Gamboni, Alessandro
    Chiari, Rita
    Bennati, Chiara
    Calistri, Daniele
    Ludovini, Vienna
    Crino, Lucio
    Amadori, Dino
    Ulivi, Paola
    CLINICAL CANCER RESEARCH, 2017, 23 (09) : 2195 - 2202
  • [10] Inherited mutations of DNA damage repair genes in a racially diverse cohort of men with prostate cancer
    Kohaar, Indu
    Zhang, Xijun
    Chesnut, Gregory
    Dalgard, Clifton
    Wilkerson, Matthew D.
    Petrovics, Gyorgy
    CANCER RESEARCH, 2023, 83 (11)
12345